$BRVE insider trading
Over the last 12 months, Braveheart Bio insiders reported 11 buys totaling $159.0M and no sales across SEC Form 4 filings.
- Bought · 12m
- $159.0M 11 events
- Sold · 12m
- — 0 events
- Events · 12m
- 11 Form 4 filings, grouped
- Insiders · 12m
- 10 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | AH Bio Fund IV, L.P.10% | ▲ Buy | 1,100,000 | $18 | $19.8M | +12% | indirect |
| Aug 7, 2026 | Chimovits ErezD·10% | ▲ Buy | 1,940,000 | $18 | $34.9M | — | 2 tranches · indirect |
| Aug 7, 2026 | ORBIMED ADVISORS LLCD·10% | ▲ Buy | 1,940,000 | $18 | $34.9M | — | 2 tranches · indirect |
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A.10% | ▲ Buy | 1,680,000 | $18 | $30.2M | +19.8% | indirect |
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A.10% | ▲ Buy | 1,920,000 | $18 | $34.6M | +19.8% | — |
| Aug 7, 2026 | Rickey James PaulChief Financial Officer · O | ▲ Buy | 27,777 | $18 | $500K | +5.6% | — |
| Aug 7, 2026 | Viehbacher ChristopherD | ▲ Buy | 83,333 | $18 | $1.5M | +15.8% | — |
| Aug 7, 2026 | Malek David ID | ▲ Buy | 4,166 | $18 | $75K | +0.8% | — |
| Aug 7, 2026 | Anderson Michele A.Chief Development Officer · O | ▲ Buy | 1,111 | $18 | $20K | +0.3% | — |
| Aug 7, 2026 | Murdoch TravisCEO and President · O·D | ▲ Buy | 83,333 | $18 | $1.5M | +2.9% | — |
| Aug 7, 2026 | Lubner David CharlesD | ▲ Buy | 55,555 | $18 | $1000K | — | — |
Every $BRVE filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Braveheart Bio filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BRVE feed.